FDA Approves Xifyrm (meloxicam) Injection for the Management of Moderate-to-Severe Pain in Adults

Jun 11, 2025 - 13:00
 0  0
FDA Approves Xifyrm (meloxicam) Injection for the Management of Moderate-to-Severe Pain in Adults
Woburn, MA — June 10, 2025 — Azurity Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Xifyrm (meloxicam injection) an IV non-steroidal anti-inflammatory drug (NSAID) that offers once...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0